BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+17%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.04B
AUM Growth
+$2.04B
Cap. Flow
+$64.9M
Cap. Flow %
3.19%
Top 10 Hldgs %
54.88%
Holding
72
New
11
Increased
1
Reduced
5
Closed
4

Top Buys

1
TIL icon
Instil Bio
TIL
$23.9M
2
KYMR icon
Kymera Therapeutics
KYMR
$21.3M
3
NRIX icon
Nurix Therapeutics
NRIX
$12.7M
4
QURE icon
uniQure
QURE
$11M
5
APGE icon
Apogee Therapeutics
APGE
$10.5M

Top Sells

1
FATE icon
Fate Therapeutics
FATE
$11.4M
2
ALLO icon
Allogene Therapeutics
ALLO
$8.97M
3
NKTX icon
Nkarta
NKTX
$7.13M
4
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
$7.08M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
$2.85M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SRRK icon
51
Scholar Rock
SRRK
$3.14B
$6.01M 0.29%
+750,000
New +$6.01M
PSTX
52
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$5.72M 0.28%
2,000,000
-2,475,000
-55% -$7.08M
SMMT icon
53
Summit Therapeutics
SMMT
$17.6B
$5.48M 0.27%
+250,000
New +$5.48M
ENGN icon
54
enGene Holdings
ENGN
$236M
$4.8M 0.24%
727,900
– –
PRLD icon
55
Prelude Therapeutics
PRLD
$68.5M
$3.54M 0.17%
1,708,187
-860,100
-33% -$1.78M
BCAX
56
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$3.44M 0.17%
+135,000
New +$3.44M
MRSN icon
57
Mersana Therapeutics
MRSN
$36.5M
$3.43M 0.17%
+1,817,000
New +$3.43M
BOLD
58
Boundless Bio
BOLD
$25.1M
$2.47M 0.12%
711,329
– –
BDTX icon
59
Black Diamond Therapeutics
BDTX
$157M
$2.2M 0.11%
506,000
– –
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$122M
$1.66M 0.08%
450,000
– –
TARA icon
61
Protara Therapeutics
TARA
$120M
$1.49M 0.07%
811,627
– –
OBIO icon
62
Orchestra BioMed
OBIO
$147M
$1.22M 0.06%
238,193
– –
ZURA icon
63
Zura Bio
ZURA
$133M
$1.22M 0.06%
+300,000
New +$1.22M
BCAB icon
64
BioAtla
BCAB
$26.7M
$1.21M 0.06%
686,347
– –
MIST icon
65
Milestone Pharmaceuticals
MIST
$156M
$470K 0.02%
309,007
– –
DBVT
66
DBV Technologies
DBVT
$264M
$175K 0.01%
250,000
– –
NUVB.WS icon
67
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$26.1K ﹤0.01%
266,666
– –
SRZNW icon
68
Surrozen, Inc. Warrant
SRZNW
$71.6K
$1.33K ﹤0.01%
66,666
– –
ABSI icon
69
Absci
ABSI
$357M
– –
-700,000
Closed -$2.16M
ALLO icon
70
Allogene Therapeutics
ALLO
$251M
– –
-3,850,000
Closed -$8.97M
AMLX icon
71
Amylyx Pharmaceuticals
AMLX
$836M
– –
-1,500,000
Closed -$2.85M
ATRA icon
72
Atara Biotherapeutics
ATRA
$84.6M
– –
-166,000
Closed -$1.41M
1 2
3